Novel anti-phage resistance mechanisms channelled through transcriptional regulation
Novel anti-phage resistance mechanisms channelled through transcriptional regulation
批准号:
464976318
负责人:
Professorin Dr. Debbie Lindell, Ph.D.
金额:
$0.0万
依托单位国家:
德国
项目类别:
Priority Programmes
财政年份:
--
资助国家:
德国
项目状态:
未结题
起止时间:
中文摘要
聚球藻属和原氯球藻属的海洋单细胞蓝藻是世界海洋中重要的初级生产者。它们与大量噬藻体共存可能是由于有效的抗性机制所致。在此之前,我们已经证明了多面手(广泛宿主范围)T4类噬藻体在多个敏感宿主菌株中具有相同的转录程序。由于这一噬菌体家族不编码自己的RNA聚合酶,它必须篡夺宿主的RNA聚合酶。该程序在分子水平上被调控的方式与T4原型噬菌体显著不同,目前仍不清楚。此外,我们已经证明,一般的噬藻体附着并进入耐药蓝细菌细胞,但不完成感染周期。耐药蓝藻暂停感染的一个共同特征是噬菌体基因转录显著减少。这些海洋蓝藻中的绝大多数缺乏已知的抗性机制,如CRISPR-CAS或限制性内切酶修饰系统。这表明目前未知的细胞内防御机制正在发挥作用。在这个优先计划中,我们的目标是解决海洋T4类噬菌体的噬菌体转录程序如何在敏感蓝藻中受到调控的核心问题,并阐明在耐药蓝藻中在转录水平上发挥作用的防御机制。我们的具体目标是:(1)识别调节噬菌体启动子的宿主和噬菌体因子;(2)阐明与宿主RNA聚合酶相互作用的噬菌体因子;(3)研究关键宿主和噬菌体蛋白在噬菌体转录中的作用;以及(4)发现降低转录的蓝藻抗性机制。我们将使用类似T4的噬藻体Syn9,以及敏感的聚球菌WH8109和抗性的聚球菌CC9311作为我们的模型系统,所有这些都可以进行基因操作。为了实现这些目标,我们将鉴定直接参与调节噬菌体启动子活性和调控转录的噬菌体和宿主蛋白。我们将确定这是通过与噬菌体启动子的直接相互作用还是通过对宿主RNA聚合酶的化学修饰或蛋白质-蛋白质相互作用来实现的。我们将产生缺乏这些因素的突变株,以评估对感染过程的影响。此外,我们将确定是什么抑制了抗药性蓝藻中的噬菌体转录程序。这项研究将为海洋T4样噬藻体调节其相对于T4原型的转录程序的新方法提供基本信息。此外,这将为发现在转录水平发挥作用的新的抗病毒防御系统奠定基础。因此,这项研究计划将在理解这一具有生态重要性的有机体群体中宿主与病毒的相互作用方面开辟新的视野。
英文摘要
Marine unicellular cyanobacteria of the genera Synechococcus and Prochlorococcus are important primary producers in the world’s oceans. Their coexistence with high abundances of cyanophages is likely due to effective mechanisms of resistance. Previously, we have shown that generalist (broad host-range) T4-like cyanophages have identical transcriptional programs in multiple sensitive host strains. Since this family of phages does not code for its own RNA polymerase it must usurp that of its hosts. The means through which this program is regulated at the molecule level is significantly different to the T4 archetype phage and remains unknown. In addition, we have shown that generalist cyanophages attach and enter into resistant cyanobacterial cells, yet do not complete the infection cycle. A common feature of halted infections in resistant cyanobacteria is significantly reduced transcription of phage genes. The vast majority of these marine cyanobacteria lack known resistance mechanisms such as CRISPR-Cas or restriction-modification systems. This indicates that presently unknown intracellular defense mechanisms are at play. In this priority program our objectives are to address the central question of how the phage transcriptional program of marine T4-like cyanophages is regulated in sensitive cyanobacteria and to elucidate the mechanisms of defence that function at the transcriptional level in resistant cyanobacteria. Our specific objectives are to: (1) Identify host and phage factors that regulate phage promoters; (2) Elucidate phage factors that interact with the host RNA polymerase; (3) Investigate the role of key host and phage proteins in phage transcription; and (4) Discover cyanobacterial resistance mechanisms that reduce transcription. We will use the T4-like cyanophage, Syn9, with the sensitive Synechococcus WH8109 and resistant Synechococcus CC9311 as our model system, all of which can be genetically manipulated. To achieve these aims we will identify phage and host proteins that are directly involved in regulation of phage promoter activity and modulate transcription. We will determine whether this is through direct interaction with phage promoters or through the chemical modification of, or protein-protein interactions with, the host RNA polymerase. We will generate mutants lacking these factors to assess the impact on the infection process. Furthermore, we will ascertain what inhibits the phage transcriptional program in the resistant cyanobacterium. This study will provide fundamental information on the novel means through which the marine T4-like cyanophages regulate their transcriptional program relative to that in the T4 archetype. Furthermore, this will lay the groundwork for the discovery of new anti-viral defence systems that function at the transcriptional level. As such this research program will open up new horizons in the understanding of host-virus interactions in this ecologically important group of organisms.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
Anti-LAG3工程化DC囊泡疫苗的免疫效应及质控体系研究
-
批准号:32560236
-
项目类别:地区科学基金项目
-
资助金额:32.00万元
-
批准年份:2025
-
负责人:左文宝
-
依托单位:
基于spA-Gel负载Anti-HMGB1原位靶向免疫耐受的猪胰岛类器官移植研
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:程瑶
-
依托单位:
TKIs氘代化修饰通过促进HCC铁死亡增强免疫原性并增敏anti-PD-1治疗的机制研究
-
批准号:JCZRQN202500319
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
肺癌外周血淋巴细胞亚群预测anti-PD1/PDL1疗效的鉴定及应用研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:仇凤启
-
依托单位:
构建α-突触核蛋白特异性CAR-Treg治疗抗NMDAR脑炎的研究
-
批准号:2025JJ80620
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:刘钰
-
依托单位:
Anti-MDA5阳性皮肌炎病人的NK细胞数量与功能改变在间质性肺疾病中的作用与机制研究
-
批准号:MS25H100014
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:韩咏梅
-
依托单位:
图的anti-Ramsey问题的研究
-
批准号:12571380
-
项目类别:面上项目
-
资助金额:44.00万元
-
批准年份:2025
-
负责人:金泽民
-
依托单位:
CCL2介导PGK1的O-GlcNAc糖基化修饰诱导CAFs代谢重编程促进头颈癌anti-PD-1免疫治疗耐药的机制研究
-
批准号:
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:苑振楠
-
依托单位:
特发性膜性肾病血清标志物anti-PLA2R-IgG4检测方法的建立及临床应用
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:徐燕
-
依托单位:
经 anti-GPC3 修饰的外泌体靶向递送索拉非尼与放疗联合诱
导肝细胞癌铁死亡的研究
-
批准号:2024JJ9608
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:段和新
-
依托单位: